GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daiichi Sankyo Co Ltd (OTCPK:DSNKY) » Definitions » Cyclically Adjusted Book per Share

Daiichinkyo Co (Daiichinkyo Co) Cyclically Adjusted Book per Share : $4.71 (As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Daiichinkyo Co Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Daiichinkyo Co's adjusted book value per share for the three months ended in Mar. 2024 was $5.876. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $4.71 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Daiichinkyo Co's average Cyclically Adjusted Book Growth Rate was 7.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 7.80% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 6.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Daiichinkyo Co was 7.80% per year. The lowest was 3.30% per year. And the median was 5.30% per year.

As of today (2024-06-08), Daiichinkyo Co's current stock price is $37.08. Daiichinkyo Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $4.71. Daiichinkyo Co's Cyclically Adjusted PB Ratio of today is 7.87.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Daiichinkyo Co was 7.92. The lowest was 1.57. And the median was 4.52.


Daiichinkyo Co Cyclically Adjusted Book per Share Historical Data

The historical data trend for Daiichinkyo Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daiichinkyo Co Cyclically Adjusted Book per Share Chart

Daiichinkyo Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.96 5.12 4.89 4.95 4.71

Daiichinkyo Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.95 4.66 4.53 4.89 4.71

Competitive Comparison of Daiichinkyo Co's Cyclically Adjusted Book per Share

For the Drug Manufacturers - General subindustry, Daiichinkyo Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daiichinkyo Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Daiichinkyo Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Daiichinkyo Co's Cyclically Adjusted PB Ratio falls into.



Daiichinkyo Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Daiichinkyo Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=5.876/107.2000*107.2000
=5.876

Current CPI (Mar. 2024) = 107.2000.

Daiichinkyo Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 4.527 98.000 4.952
201409 4.552 98.500 4.954
201412 4.393 97.900 4.810
201503 5.128 97.900 5.615
201506 4.890 98.400 5.327
201509 4.995 98.500 5.436
201512 5.035 98.100 5.502
201603 5.319 97.900 5.824
201606 5.490 98.100 5.999
201609 5.563 98.000 6.085
201612 5.154 98.400 5.615
201703 5.234 98.100 5.720
201706 5.396 98.500 5.873
201709 5.439 98.800 5.901
201712 5.405 99.400 5.829
201803 5.499 99.200 5.942
201806 5.665 99.200 6.122
201809 5.730 99.900 6.149
201812 5.665 99.700 6.091
201903 5.785 99.700 6.220
201906 5.971 99.800 6.414
201909 6.088 100.100 6.520
201912 6.271 100.500 6.689
202003 6.238 100.300 6.667
202006 6.290 99.900 6.750
202009 6.495 99.900 6.970
202012 6.433 99.300 6.945
202103 6.107 99.900 6.553
202106 6.696 99.500 7.214
202109 6.861 100.100 7.348
202112 6.736 100.100 7.214
202203 5.943 101.100 6.302
202206 5.453 101.800 5.742
202209 5.342 103.100 5.554
202212 5.469 104.100 5.632
202303 5.642 104.400 5.793
202306 5.645 105.200 5.752
202309 5.623 106.200 5.676
202312 5.746 106.800 5.768
202403 5.876 107.200 5.876

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Daiichinkyo Co  (OTCPK:DSNKY) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Daiichinkyo Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=37.08/4.71
=7.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Daiichinkyo Co was 7.92. The lowest was 1.57. And the median was 4.52.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Daiichinkyo Co Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Daiichinkyo Co's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Daiichinkyo Co (Daiichinkyo Co) Business Description

Traded in Other Exchanges
Address
3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, JPN, 103-8426
Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2021, approximately half of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates. Its three lead ADCs are Enhertu (HER2), Dato-DXd (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu entered the clinic in 2015 and received its first U.S approval in December 2019 for third-line late-stage HER2-positive breast cancer. It is also approved for HER2-positive stomach cancers and HER2 mutant non-small cell lung cancer.